Skip to main content
. 2021 Jan 11;11:30. doi: 10.1038/s41398-020-01124-6

Table 3.

Primary, secondary and other pre-specified outcome measures by condition.

Continuous outcome Intervention (total n = 22) Control (total n = 19) Effect size
n Mean SD n Mean SD d 95% CI for d
Primary outcome, Week 1
 Number of intrusive memories (diary) 20 3.85a 8.57 19 7.37 7.88 0.43 −0.23, 1.08
Secondary outcome, Week 5
 Number of intrusive memories (diary) 18 0.28 0.57 18 2.89 6.43 0.57 −0.12, 1.26
Secondary outcomes, 1 week
 IES-R
  Intrusion subscale 16 4.12 4.13 17 8.53 6.23 0.83 0.09, 1.57
  Avoidance subscale 16 2.38 2.42 17 8.06 7.85 0.97 0.22, 1.72
 HADS
   Anxiety subscale 16 3.25 2.89 17 4.71 3.64 0.44 −0.28, 1.16
   Depression subscale 16 1.62 1.89 17 3.06 3.36 0.52 −0.20, 1.24
   Total 16 4.88 4.62 17 7.76 6.81 0.49 −0.23, 1.22
Other outcomes, 1 week
 SRHR 16 5.62 1.36 16 5.12 1.54 −0.34 −1.07, 0.38
 SRSR 16 5.81 2.17 16 4.88 2.53 −0.40 −1.13, 0.33
 Intrusion-related distress 13 2.00 2.55 16 3.38 3.42 0.45 −0.33, 1.22
 Intrusion vividness 13 2.85 3.44 16 4.50 3.46 0.48 −0.30, 1.26
 Concentration disruption 16 1.38 0.72 16 2.39 1.65 0.80 0.05, 1.55
Secondary outcomes, 1 month
 IES-R
  Intrusion subscale 16 1.88 2.39 18 3.78 3.72 0.60 −0.11, 1.32
  Avoidance subscale 16 1.94 4.55 18 3.39 4.27 0.33 −0.38, 1.03
 HADS
  Anxiety subscale 16 3.19 3.02 18 3.83 3.07 0.21 −0.49, 0.91
  Depression subscale 16 2.12 3.24 18 2.72 3.63 0.17 −0.53, 0.87
  Total 16 5.31 5.76 18 6.56 6.06 0.21 −0.49, 0.91
Other outcomes, 1 month
 SRHR 16 5.06 1.84 18 5.00 1.28 −0.04 −0.74, 0.66
 SRSR 16 6.69 1.40 18 5.67 2.68 −0.47 −1.18, 0.24
 Intrusion-related distress 13 1.69 3.45 16 1.25 2.24 −0.16 −0.92, 0.61
 Intrusion vividness 13 1.08 2.29 16 1.88 2.53 0.33 −0.44, 1.10
Concentration disruption 15 1.27 1.03 18 1.83 1.50 0.43 −0.29, 1.15
Secondary outcomes, 3 months
 IES-R
  Intrusion subscale 15 1.33 2.13 18 2.33 2.83 0.39 −0.33,1.11
  Avoidance subscale 15 0.80 1.26 18 1.61 2.85 0.36 −0.36,1.07
 HADS
  Anxiety subscale 14 2.36 2.90 18 3.22 3.15 0.28 −0.45,1.02
  Depression subscale 14 1.43 1.91 18 2.17 2.50 0.33 −0.41,1.06
  Total 14 3.79 4.66 18 5.39 5.40 0.31 −0.42,1.05
Other outcomes, 3 months
 SRHR 14 5.57 1.34 18 5.44 0.86 −0.12 −0.84,0.61
 SRSR 14 7.21 1.19 18 6.28 2.27 −0.50 −1.24,0.24
 Concentration disruption 14 1.43 1.60 18 1.56 1.15 0.09 −0.64,0.82
Secondary outcomes, 6 months
 IES-R
  Intrusion subscale 12 1.33 3.47 16 0.75 1.13 −0.24 −1.03,0.55
  Avoidance subscale 12 0.42 0.90 15 0.93 1.33 0.44 −0.36,1.25
HADS
  Anxiety subscale 12 2.08 2.50 16 3.44 3.22 0.46 −0.33,1.26
  Depression subscale 12 1.08 1.68 15 1.87 1.81 0.45 −0.36,1.25
  Total 12 3.17 4.02 15 5.53 4.66 0.54 −0.27,1.35
Other outcomes, 6 months
 SRHR 12 5.83 1.34 16 5.38 1.36 −0.34 −1.13,0.45
 SRSR 12 7.25 0.87 16 5.12 2.66 −1.01 −1.85,−0.18
 Concentration disruption 12 1.58 1.73 15 1.27 0.70 −0.25 −1.05,0.55

CI confidence interval, HADS Hospital Anxiety and Depression Scale, IES-R Impact of Event Scale–Revised, SRHR Self Rated Health Rating, SRSR Self Rated Sleep Rating.

aTable 3 reports the analysis including all participants (incl. outliers). Outliers in number of intrusive memories were inspected per group separately, and were identified based on standard criteria (i.e., >3 SD51). For week 1 data, one statistical outlier was detected within the intervention group (reported 37 intrusions). This participant did not receive correct protocol delivery in ED. For completeness, the outlier is included in the descriptive analyses reported here. No outliers were detected for week 5 data.